showing

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

July 22, 2025 02:00 ET  | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…

2 days ago

HeraldEX Defines the Future with Its One-Stop Crypto Platform for Businesses

WARSAW, Poland, July 14, 2025 /PRNewswire/ -- At Crypto Expo Dubai 2025, HeraldEX launched two of its highly awaited tools:…

1 week ago

Vantage Shines at Money Expo Colombia 2025 with Industry Recognition and Dynamic Engagement

PORT VILA, Vanuatu, July 4, 2025 /PRNewswire/ -- Vantage Markets wrapped up a highly successful showing at Money Expo Colombia…

3 weeks ago

New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure

Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20, 2025 /PRNewswire/ -- The International Society of Aesthetic…

1 month ago

Articul8 Showcases Multi-Agent Reasoning System to Advance Aerospace Engineering at Paris Air Show

SANTA CLARA, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Articul8, a leading enterprise GenAI company, today unveiled its next-generation multi-agent…

1 month ago